Monish Karunakaran1,2, Ramneek Kaur3, Simi Ismail4, Sushma Cherukuru5, Pavan Kumar Jonnada6, Baiju Senadhipan1, Savio George Barreto7,8. 1. Department of Surgical Gastroenterology, Asian Institute of Gastroenterology, Hyderabad, India. 2. College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia. 3. Department of Anesthesiology, Institute of Liver Transplantation & Regenerative Medicine, Medanta-The Medicity, Gurugram, India. 4. Department of Radiology, KIMS Hospital, Thiruvananthapuram, India. 5. Department of Pathology, ESI Hospital, Hyderabad, India. 6. Department of Surgical Oncology, Basavatarakam Indo-American Cancer Hospital & Research Institute, Hyderabad, India. 7. College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia. georgebarreto@yahoo.com. 8. Division of Surgery and Perioperative Medicine, Flinders Medical Center, Bedford Park, Adelaide, South Australia, Australia. georgebarreto@yahoo.com.
Abstract
PURPOSE: Patients undergoing hepatectomy are at moderate-to-high risk of venous thromboembolism (VTE). This study critically examines the efficacy of combining pharmacological (PTP) and mechanical thromboprophylaxis (MTP) versus only MTP in reducing VTE events against the risk of hemorrhagic complications. METHODS: A systematic review of major reference databases was undertaken, and a meta-analysis was performed using common-effects model. Risk of bias assessment was performed using Newcastle-Ottawa scale. Trial sequential analysis (TSA) was used to assess the precision and conclusiveness of the results. RESULTS: 8 studies (n = 4238 patients) meeting inclusion criteria were included in the analysis. Use of PTP + MTP was found to be associated with significantly lower VTE rates compared to only MTP (2.5% vs 5.3%; pooled RR 0.50, p = 0.03, I2 = 46%) with minimal type I error. PTP + MTP was not associated with an increased risk of hemorrhagic complications (3.04% vs 1.9%; pooled RR 1.54, p = 0.11, I2 = 0%) and had no significant impact on post-operative length of stay (12.1 vs 10.8 days; pooled MD - 0.66, p = 0.98, I2 = 0%) and mortality (2.9% vs 3.7%; pooled RR 0.73, p = 0.33, I2 = 0%). CONCLUSION: Despite differences in the baseline patient characteristics, extent of hepatectomy, PTP regimens, and heterogeneity in the pooled analysis, the current study supports the use of PTP in post-hepatectomy patients (grade of recommendation: strong) as the combination of PTP + MTP is associated with a significantly lower incidence of VTE (level of evidence, moderate), without an increased risk of post-hepatectomy hemorrhage (level of evidence, low).
PURPOSE: Patients undergoing hepatectomy are at moderate-to-high risk of venous thromboembolism (VTE). This study critically examines the efficacy of combining pharmacological (PTP) and mechanical thromboprophylaxis (MTP) versus only MTP in reducing VTE events against the risk of hemorrhagic complications. METHODS: A systematic review of major reference databases was undertaken, and a meta-analysis was performed using common-effects model. Risk of bias assessment was performed using Newcastle-Ottawa scale. Trial sequential analysis (TSA) was used to assess the precision and conclusiveness of the results. RESULTS: 8 studies (n = 4238 patients) meeting inclusion criteria were included in the analysis. Use of PTP + MTP was found to be associated with significantly lower VTE rates compared to only MTP (2.5% vs 5.3%; pooled RR 0.50, p = 0.03, I2 = 46%) with minimal type I error. PTP + MTP was not associated with an increased risk of hemorrhagic complications (3.04% vs 1.9%; pooled RR 1.54, p = 0.11, I2 = 0%) and had no significant impact on post-operative length of stay (12.1 vs 10.8 days; pooled MD - 0.66, p = 0.98, I2 = 0%) and mortality (2.9% vs 3.7%; pooled RR 0.73, p = 0.33, I2 = 0%). CONCLUSION: Despite differences in the baseline patient characteristics, extent of hepatectomy, PTP regimens, and heterogeneity in the pooled analysis, the current study supports the use of PTP in post-hepatectomy patients (grade of recommendation: strong) as the combination of PTP + MTP is associated with a significantly lower incidence of VTE (level of evidence, moderate), without an increased risk of post-hepatectomy hemorrhage (level of evidence, low).
Authors: Randall R De Martino; Philip P Goodney; Emily L Spangler; Jessica B Wallaert; Matthew A Corriere; Eva M Rzucidlo; Daniel B Walsh; David H Stone Journal: J Vasc Surg Date: 2012-03-10 Impact factor: 4.268
Authors: Michael K Gould; David A Garcia; Sherry M Wren; Paul J Karanicolas; Juan I Arcelus; John A Heit; Charles M Samama Journal: Chest Date: 2012-02 Impact factor: 9.410
Authors: Hari Nathan; Matthew J Weiss; Gerald A Soff; Michelle Stempel; Ronald P Dematteo; Peter J Allen; T Peter Kingham; Yuman Fong; William R Jarnagin; Michael I D'Angelica Journal: J Gastrointest Surg Date: 2013-10-16 Impact factor: 3.452
Authors: Paul G Shekelle; Peter J Pronovost; Robert M Wachter; Kathryn M McDonald; Karen Schoelles; Sydney M Dy; Kaveh Shojania; James T Reston; Alyce S Adams; Peter B Angood; David W Bates; Leonard Bickman; Pascale Carayon; Liam Donaldson; Naihua Duan; Donna O Farley; Trisha Greenhalgh; John L Haughom; Eileen Lake; Richard Lilford; Kathleen N Lohr; Gregg S Meyer; Marlene R Miller; Duncan V Neuhauser; Gery Ryan; Sanjay Saint; Stephen M Shortell; David P Stevens; Kieran Walshe Journal: Ann Intern Med Date: 2013-03-05 Impact factor: 25.391
Authors: Srinevas K Reddy; Ryan S Turley; Andrew S Barbas; Jennifer L Steel; Allan Tsung; J Wallis Marsh; Bryan M Clary; David A Geller Journal: J Gastrointest Surg Date: 2011-06-21 Impact factor: 3.452
Authors: Timothy E Newhook; Damien J LaPar; Dustin M Walters; Shruti Gupta; Joshua S Jolissaint; Reid B Adams; Kenneth L Brayman; Victor M Zaydfudim; Todd W Bauer Journal: Am Surg Date: 2015-12 Impact factor: 0.688
Authors: Selwyn O Rogers; Ravi K Kilaru; Patrick Hosokawa; William G Henderson; Michael J Zinner; Shukri F Khuri Journal: J Am Coll Surg Date: 2007-06 Impact factor: 6.113